Joris Hoefinghoff

This inventor holds 12 USPTO granted patents and 12 published patent applications, plus 7 CIPO patents and 8 EPO patents. Top assignees: Baxter International Inc., Baxter Healthcare Sa. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joris Hoefinghoff. Retrieved from https://idiyas.com/inventor/joris-hoefinghoff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 12)

% Patents Active = 91.7

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 45(Granted Patents)

Company Filing History:

12 out of 2,533

Baxter International Inc.

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12576181 - Hemostatic sponge (2026-03-17),

2. 11478566 - Hemostatic sponge (2022-10-25),

3. 11071804 - Hemostatic sponge (2021-07-27),

4. 10441674 - Hemostatic sponge (2019-10-15),

5. 10322170 - Hemostatic compositions (2019-06-18),

6. 9872934 - Hemostatic sponge (2018-01-23),

7. 9821025 - Hemostatic compositions (2017-11-21),

8. 9517287 - Hemostatic sponge (2016-12-13),

9. 9375505 - Hemostatic sponge (2016-06-28),

10. 9162006 - Hemostatic sponge (2015-10-20),

11. 8771258 - Hemostatic sponge (2014-07-08),

12. 8703170 - Hemostatic sponge (2014-04-22),

Title: Joris Hoefinghoff: Innovator in Hemostatic Technology

Introduction

Joris Hoefinghoff is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medical technology, particularly in the development of hemostatic products. With a total of 12 patents to his name, Hoefinghoff has established himself as a key figure in innovation.

Latest Patents

Among his latest inventions is a hemostatic sponge, which is a porous composite designed to control bleeding. This invention includes a hemostatic composite sponge made from oxidized cellulose and a bioadhesive material that is gelatin-free. The unique design of this sponge allows for an organized pattern of the bioadhesive material, enhancing its effectiveness in medical applications.

Career Highlights

Hoefinghoff has worked with prominent companies in the medical field, including Baxter International Inc. and Baxter Healthcare SA. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in hemostatic technology.

Collaborations

Throughout his career, Hoefinghoff has collaborated with various professionals, including Hans Christian Hedrich and Woonza M Rhee. These partnerships have fostered a creative environment that has led to the development of innovative medical solutions.

Conclusion

Joris Hoefinghoff's work in the field of hemostatic technology exemplifies the impact of innovation in medicine. His contributions continue to advance the effectiveness of medical treatments and improve patient outcomes.

Profile summary based on public USPTO records.